Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
Clinical trial NCT03097861 · COMPLETED
Trial details
- NCT number
- NCT03097861
- Sponsor
- Sucampo Pharma Americas, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-13
- Primary completion
- 2017-08-17
- Enrollment
- 552
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.